Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINIK FOR FYSIOTERAPI HOLBERGSGADE 13 (AUTORISERET FYSIOTERAPEUT) ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.9% 1.9% 1.8% 1.8% 1.8% 11.2% 10.6% 10.6%   Credit score (0-100)   72 71 70 70 71 22 23 23   Credit rating   A A A A A BB BB BB   Credit limit (kDKK)   1.7 1.5 2.1 1.7 2.7 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,546 2,882 3,171 3,823 3,548 15,774 0.0 0.0   EBITDA   1,748 796 1,217 1,815 1,351 13,657 0.0 0.0   EBIT   1,266 332 753 1,341 890 13,208 0.0 0.0   Pre-tax profit (PTP)   1,297.5 383.1 815.0 1,399.8 913.2 13,187.9 0.0 0.0   Net earnings   1,005.9 297.3 635.3 1,088.9 711.1 10,278.4 0.0 0.0   Pre-tax profit without non-rec. items   1,301 383 815 1,400 913 13,188 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   119 143 280 255 198 0.0 0.0 0.0   Shareholders equity total   3,860 3,553 3,246 3,191 2,998 12,394 5,144 5,144   Interest-bearing liabilities   140 915 845 1,173 2,356 2,285 0.0 0.0   Balance sheet total (assets)   5,407 5,692 5,597 5,559 6,401 18,290 5,144 5,144   Net Debt   138 912 841 1,171 2,353 2,280 -5,144 -5,144     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,546 2,882 3,171 3,823 3,548 15,774 0.0 0.0   Gross profit growth   5.2% -18.7% 10.0% 20.6% -7.2% 344.6% -100.0% 0.0%   Employees   4 6 6 6 7 6 0 0   Employee growth %   0.0% 50.0% 0.0% 0.0% 16.7% -14.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,407 5,692 5,597 5,559 6,401 18,290 5,144 5,144   Balance sheet change%   -3.6% 5.3% -1.7% -0.7% 15.1% 185.7% -71.9% 0.0%   Added value   1,748.3 795.6 1,217.0 1,814.9 1,363.7 13,656.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,055 -854 -741 -913 -924 -1,446 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   35.7% 11.5% 23.7% 35.1% 25.1% 83.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   24.3% 7.7% 15.2% 25.9% 16.9% 108.2% 0.0% 0.0%   ROI %   28.6% 8.9% 17.8% 31.3% 19.8% 132.1% 0.0% 0.0%   ROE %   26.8% 8.0% 18.7% 33.8% 23.0% 133.6% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   71.4% 62.4% 58.0% 57.4% 46.8% 67.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   7.9% 114.7% 69.1% 64.5% 174.1% 16.7% 0.0% 0.0%   Gearing %   3.6% 25.8% 26.0% 36.8% 78.6% 18.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.3% 8.7% 4.8% 4.5% 5.5% 7.2% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   2.8 2.2 1.9 2.0 1.7 3.1 0.0 0.0   Current Ratio   2.8 2.2 1.9 2.0 1.7 3.1 0.0 0.0   Cash and cash equivalent   1.9 2.6 3.1 1.9 3.0 5.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,760.6 1,844.0 1,731.1 2,031.8 2,217.6 12,394.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   437 133 203 302 195 2,276 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   437 133 203 302 193 2,276 0 0   EBIT / employee   317 55 125 223 127 2,201 0 0   Net earnings / employee   251 50 106 181 102 1,713 0 0